维普期刊资源整合服务平台（V6.5）

71篇 您的检索式：作者名="LABINAZ M"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Robust viability of hybrid systems 显示文摘	Labinaz G Guay M	2008	Nonlinear Analysis : Hybrid Systems2008，，2：	1
2	Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention显示文摘	Goncalves SC Labinaz M Le May M	2011	Am J Cardiol2011，107，：	1
3	Meta-analysis of clinical efficacy and bleeding risk with intravenous GP IIb/IIIa antagonists for percutaneous coronary intervention显示文摘	Labinaz M Ho C Banerjee S	2007	Can J Cardiol2007，23，12：	1
4	A survey of modeling and control of hybrid systems显示文摘	Labinaz G Bayoumi M M Rudie K	1997	Annual Reviews in Control1997，21，：	1
5	Time course and importance of neoadventitial formation in arterial remodeling following balloon angioplasty of porcine coronary arteries显示文摘	Labinaz M Pels K Hoffert C	1999	Cardiaovasc Res1999，41，：	1
6	Meta-analysis of clinical efficacy and bleeding risk with intravenous glycoprotein Ⅱb/Ⅲa an tagonists for percutaneous coronary intervention显示文摘	Labinaz M Ho C Banerjee S	2007	Can J Cardiol2007，23，12：	1
7	Usefulness of mean platelet volume as a biomarker for long-term outcomes after percuta- neous coronary intervention显示文摘	Goncalves SC Labinaz M Le May M	2011	Am J Cardiol2011，107，2：	1
8	Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention 显示文摘	Goncalves SC Labinaz M Le May M	2011	AM J Cardiol2011，107，：	1
9	Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention显示文摘	Goncalves SC Labinaz M Le May M	2011	Am J Cardiol2011，107，2：	1
10	Meta-analysis of clinical efficacy and bleeding risk with intravenous glyco-protein Ⅱ b/Ⅲ a antagonists for percutaneous coronary in-tervention显示文摘	Ho C Banerjee S	2007	Can J Cardiol2007，23，12：	1
11	Tune course and importance of neoadventitial formation in arterial mnodeling following balloon angioplasty of porcine coronary arteries显示文摘	Labinaz M Pels K Hoffert C	1999	Cardiovasc Res1999，41，1：	1
12	Delivery of primary percutaneouscoronary intervention for the management of acute ST segment elevationmyocardial infarction : summary of the Cardiac CareNetwork of OntarioConsensus Report显示文摘	Labinaz M Swabey T Watson R	2006	Can J Cardilo Vol2006，22，3：	1
13	Association between completeness of pereutaneous coronary revaseularization and postprocedure outcomes显示文摘	MeLellan CS Ghali WA Labinaz M	2005	Am Heart J2005，150，4：	1
14	Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration显示文摘	Ma X Labinaz M Goldstein J	2000	Arterioscler Thromb Vasc Biol2000，20，12：	1
15	Hospitalization costs of primary stenting versus thrombolysis in acute myocardial infarction: cost analysis of the Canadian STAT Study 显示文摘	Le May MR Davies RF Labinaz M	2003	Circulation2003，108，21：	1
16	Usefulness of mean platelet volume as a biomarker for long-term outcomes after per- cutaneous coronary intervention 显示文摘	Goncalves SC Labinaz M Le MM	2011	Am J Cardiol2011，107，2：	1
17	Meta-analysis of clinical efficacy and bleeding risk with intravenous glycoprotein IIb/IIIa antagonists for percutaneous coronary intervention显示文摘	Labinaz M Ho C Banerjee S	2007	Can J Cardiol2007，23，12：	1
18	Meta-analysis of clinical efficacy and bleeding risk with intravenous GP IIb/IIIa antagonists for percutaneous coronary intervention显示文摘	Labinaz M Ho C Banerjee S	2007	Can J Cardiol2007，23，12：	1
19	Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention 显示文摘	Goncalves SC Labinaz M Lemay M	2011	Am J Cardiol2011，2，：	1
20	Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction( CAPITAL AMI study) 显示文摘	Le May MR Wells GA Labinaz M	2005	J Am Coil Cardiol2005，46，3：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示